CVS HEALTH CORPORATION Finance Lease, Right-of-Use Asset, Amortization
CVS HEALTH CORPORATION (CVS) reported Finance Lease, Right-of-Use Asset, Amortization of $90.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-02-10
- CVS HEALTH CORPORATION finance lease, right-of-use asset, amortization for the quarter ending 2019-12-31 was $11.00M.
- CVS HEALTH CORPORATION finance lease, right-of-use asset, amortization for the quarter ending 2019-09-30 was $9.00M.
- CVS HEALTH CORPORATION finance lease, right-of-use asset, amortization for the quarter ending 2019-06-30 was $9.00M.
- CVS HEALTH CORPORATION finance lease, right-of-use asset, amortization for the quarter ending 2019-03-31 was $9.00M.
- CVS HEALTH CORPORATION finance lease, right-of-use asset, amortization for fiscal 2025 was $90.00M, a 2.17% decline from fiscal 2024.
- CVS HEALTH CORPORATION finance lease, right-of-use asset, amortization for fiscal 2024 was $92.00M, a 9.52% increase from fiscal 2023.
- CVS HEALTH CORPORATION finance lease, right-of-use asset, amortization for fiscal 2023 was $84.00M, a 6.33% increase from fiscal 2022.
- CVS HEALTH CORPORATION finance lease, right-of-use asset, amortization for fiscal 2022 was $79.00M, a 27.42% increase from fiscal 2021.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2025-12-31 | $90.00M 10-K · filed 2026-02-10 | |||
| 2024-12-31 | $92.00M 10-K · filed 2026-02-10 | |||
| 2023-12-31 | $84.00M 10-K · filed 2026-02-10 | |||
| 2022-12-31 | $79.00M 10-K · filed 2025-02-12 | |||
| 2021-12-31 | $62.00M 10-K · filed 2024-02-07 | |||
| 2020-12-31 | $56.00M 8-K · filed 2023-05-25 | |||
| 2019-12-31 | $11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $20.00M derived: sum of 2 quarters · filed 2022-02-09 | $29.00M derived: sum of 3 quarters · filed 2022-02-09 | $38.00M 10-K · filed 2022-02-09 |
| 2019-09-30 | $9.00M 10-Q · filed 2019-11-06 | $18.00M derived: sum of 2 quarters · filed 2019-11-06 | $27.00M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $9.00M 10-Q · filed 2019-08-07 | $18.00M 10-Q · filed 2019-08-07 | ||
| 2019-03-31 | $9.00M 10-Q · filed 2019-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |